• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2025: $113 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Menu Menu
Sale!
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Hologic: Company Profile

$175.00 – $350.00

Clear
SKU: KLI5789984 Category: Diagnostics Market Research Pages: 21
  • Description
  • Table of Contents
  • Latest reports

Description

Hologic: Company Profile

Hologic: Company Profile examines this leading developer, manufacturer, and supplier of premium diagnostic products, medical imaging systems and surgical products. The company operates four core business units focused on diagnostics, breast health, GYN surgical and skeletal health.

Hologic, Inc. is a leading developer, manufacturer and supplier of products dedicated to women’s health. Hologic provides products for mammography and breast biopsy, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia, permanent contraception, osteoporosis assessment, preterm birth risk assessment, mini C-arm for extremity imaging and molecular diagnostic products including tests for sexually-transmitted infections (STIs) or HPV, CT/NG (Chlamydia/gonorrhea), and Trichomonas vaginalis.

Hologic participates in many markets, including

  •         Molecular Cytology / Histology (HPV)
  •         Microbiology
  •         Blood Screening
  •         Infectious Diseases
  •         Pap Smear
  •         Genetic Testing/Inherited Diseases.

The information presented in this report is the result of data gathered from government reports, company product literature and other corporate brochures and documents, as well as information found in the scientific and trade press.

Table of Contents

ONE: EXECUTIVE SUMMARY

Overview

Methodology

TWO: COMPANY PROFILE

Recent Revenue History

Company Overview

The Gen-Probe Business

Panther System

Selected Markets

Molecular Cytology / Histology (HPV)

Other Molecular (STIs, HIV, HCV, TB, Respiratory)

Microbiology (AccuProbe Molecular Culture ID Tests)

Blood Screening (Molecular PROCLEIX Tests)

Infectious Diseases

Pap Smear

Prostate Cancer

Genetic Testing/Inherited Diseases

Thrombophilia

Selected Acquisitions/Agreements

Gen-Probe

Quest Contract

Recent Hologic Developments

Aptima HBV Quant Assay

3-D Mammography

Next-Generation NovaSure GEA System

Tomcat Platform

Other Product News

 

    The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 18th Edition (2025-2030)
    September 9, 2025
    30-Country In Vitro Diagnostic (IVD) Market Atlas, 2025 (June 2025 Update)
    June 25, 2025
    In Vitro Diagnostics Business Outlook, 2025 (6 Issues)
    June 24, 2025
    Global Immunoassay Market: Trends, Technologies, and Growth Opportunities, 2025
    June 12, 2025

Related products

  • Placeholder image

    The U.S. Market for Interventional Radiology Products

    $3,500.00 – $7,000.00
  • Placeholder image

    Diagnostics for Emerging Infectious Disease Threats Volume II: Viral Disease

    $1,496.00 – $2,992.00
  • Placeholder image

    Worldwide Point of Care (POC): Are Decentralized Clinical Diagnostics a Cost Drain or Revenue Driver?

    $1,500.00 – $5,990.00
  • Placeholder image

    In Vitro Diagnostic Tests and Systems: The World Outside the United States

    $596.00 – $1,192.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • What Is the Size of the IVD Market in 2025? September 8, 2025
  • Tariff Uncertainty Disrupts Healthcare Operations: New Diagnostic Survey Highlights Staffing Changes, Delayed Purchases, and Supply Chain Strain  June 24, 2025
  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
The Global Market for Biomarkers, 2015-2020 (Cancer Markers, Cardiac Markers,...POC Urinalysis Testing Market: Forecasts to 2019
Scroll to top